RBC Life Sciences, Inc.
RBCL
$0.0001
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | 330.70K | -245.60K | -550.00K | -94.60K | -123.60K |
| Total Depreciation and Amortization | 129.90K | 149.40K | 112.90K | 128.70K | 160.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.48M | -80.80K | -248.60K | -20.70K | 33.20K |
| Change in Net Operating Assets | -1.73M | 203.60K | -177.60K | 673.80K | -501.90K |
| Cash from Operations | -2.75M | 26.60K | -863.30K | 687.20K | -431.50K |
| Capital Expenditure | -142.50K | 0.00 | -37.60K | -203.80K | -234.40K |
| Sale of Property, Plant, and Equipment | 4.82M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 40.50K | -40.50K |
| Cash from Investing | 4.68M | 0.00 | -37.60K | -163.30K | -274.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.02M | -56.80K | -55.60K | -54.70K | -53.60K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.02M | -56.80K | -55.60K | -54.70K | -53.60K |
| Foreign Exchange rate Adjustments | 277.50K | 23.40K | -42.90K | 53.80K | 45.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.18M | -6.90K | -999.50K | 523.00K | -714.80K |
